Allogeneic immunity clears latent virus following allogeneic stem cell transplantation in SIV-infected ART-suppressed macaques.
暂无分享,去创建一个
R. Siliciano | J. Siliciano | Tonya Swanson | M. Axthelm | K. Busman-Sahay | J. Estes | R. Maziarz | L. Colgin | B. Burwitz | J. Sacha | R. MacAllister | Rebecca Agnor | Helen L. Wu | T. Hobbs | B. Dozier | J. Stanton | J. Smedley | G. Meyers | L. D. Martin | Mithra Kumar | M. Sullivan | S. Bondoc | C. Shriver-Munsch | C. Moats | A. Panoskaltsis‐Mortari | S. Junell | Samantha Uttke | Joseph D Sciurba | H. Price | B. Bimber | K. Armantrout | J. Reed | R. Bochart | M. Robertson-LeVay | M. Northrup | Joseph M. Hwang | C. Waytashek | W. Weber | E. Fray | K. Bateman | S. Uttke | Sol Taylor-Brill | Alfred W Legasse | Carla D. Boyle | Mithra R Kumar
[1] J. Mellors,et al. HIV-1 remission and possible cure in a woman after haplo-cord blood transplant , 2023, Cell.
[2] T. Luedde,et al. In-depth virological and immunological characterization of HIV-1 cure after CCR5Δ32/Δ32 allogeneic hematopoietic stem cell transplantation , 2023, Nature Medicine.
[3] J. Martinez-Picado,et al. Autopsy Study Defines Composition and Dynamics of the HIV-1 Reservoir after Allogeneic Hematopoietic Stem Cell Transplantation with CCR5Δ32/Δ32 Donor Cells , 2022, Viruses.
[4] Leanne S. Whitmore,et al. Cytomegalovirus-vaccine-induced unconventional T cell priming and control of SIV replication is conserved between primate species. , 2022, Cell host & microbe.
[5] M. Axthelm,et al. Antimicrobial prophylaxis does not improve post-surgical outcomes in SIV/SHIV-uninfected or SIV/SHIV-infected macaques (Macaca mulatta and Macaca fascicularis) based on a retrospective analysis , 2022, PloS one.
[6] S. Hansen,et al. Suppression of human and simian immunodeficiency virus replication with the CCR5-specific antibody Leronlimab in two species , 2022, PLoS pathogens.
[7] A. Sylwester,et al. CCR5 Receptor Occupancy Analysis Reveals Increased Peripheral Blood CCR5+CD4+ T Cells Following Treatment With the Anti-CCR5 Antibody Leronlimab , 2021, Frontiers in Immunology.
[8] N. Haigwood,et al. Antibody-based CCR5 blockade protects Macaques from mucosal SHIV transmission , 2021, Nature Communications.
[9] R. Krance,et al. Clinical effects of administering leukemia-specific donor T cells to patients with AML/MDS post-allogeneic transplant. , 2020, Blood.
[10] Tonya Swanson,et al. Terumo spectra optia leukapheresis of cynomolgus macaques for hematopoietic stem cell and T cell collection , 2020, Journal of clinical apheresis.
[11] N. Kröger,et al. Vulnerability to reservoir reseeding due to high immune activation after allogeneic hematopoietic stem cell transplantation in individuals with HIV-1 , 2020, Science Translational Medicine.
[12] J. Martinez-Picado,et al. Evidence for HIV-1 cure after CCR5Δ32/Δ32 allogeneic haemopoietic stem-cell transplantation 30 months post analytical treatment interruption: a case report , 2020, The lancet. HIV.
[13] J. Safrit,et al. The human IL-15 superagonist N-803 promotes migration of virus-specific CD8+ T and NK cells to B cell follicles but does not reverse latency in ART-suppressed, SHIV-infected macaques , 2020, PLoS pathogens.
[14] Eisa Mahyari,et al. Viral opportunistic infections in Mauritian cynomolgus macaques undergoing allogeneic stem cell transplantation mirror human transplant infectious disease complications , 2020, Xenotransplantation.
[15] R. Siliciano,et al. The Landscape of Persistent Viral Genomes in ART-Treated SIV, SHIV, and HIV-2 Infections. , 2019, Cell host & microbe.
[16] J. Martinez-Picado,et al. HIV-1 remission following CCR5Δ32/Δ32 haematopoietic stem-cell transplantation , 2019, Nature.
[17] R. Siliciano,et al. A novel quantitative approach for measuring the reservoir of latent HIV-1 proviruses , 2019, Nature.
[18] M. Robb,et al. Prevention of SIVmac251 reservoir seeding in rhesus monkeys by early antiretroviral therapy , 2018, Nature Communications.
[19] S. Furlan,et al. Evidence for persistence of the SHIV reservoir early after MHC haploidentical hematopoietic stem cell transplantation , 2018, Nature Communications.
[20] B. Clotet,et al. Mechanisms That Contribute to a Profound Reduction of the HIV-1 Reservoir After Allogeneic Stem Cell Transplant , 2018, Annals of Internal Medicine.
[21] L. Picker,et al. Early antiretroviral therapy limits SIV reservoir establishment to delay or prevent post-treatment viral rebound , 2018, Nature Medicine.
[22] M. Kamata,et al. Long-term persistence and function of hematopoietic stem cell-derived chimeric antigen receptor T cells in a nonhuman primate model of HIV/AIDS , 2017, PLoS pathogens.
[23] Charles R. Thomas,et al. Allogeneic stem cell transplantation in fully MHC-matched Mauritian cynomolgus macaques recapitulates diverse human clinical outcomes , 2017, Nature Communications.
[24] D. Richman,et al. Extensive virologic and immunologic characterization in an HIV-infected individual following allogeneic stem cell transplant and analytic cessation of antiretroviral therapy: A case study , 2017, PLoS medicine.
[25] F. Plummer,et al. Mauritian cynomolgus macaques with M3M4 MHC genotype control SIVmac251 infection , 2017, Journal of medical primatology.
[26] Todd M. Allen,et al. Rare Control of SIVmac239 Infection in a Vaccinated Rhesus Macaque. , 2017, AIDS Research and Human Retroviruses.
[27] S. Lewin,et al. Impact of Allogeneic Hematopoietic Stem Cell Transplantation on the HIV Reservoir and Immune Response in 3 HIV-Infected Individuals , 2017, Journal of acquired immune deficiency syndromes.
[28] N. Klatt,et al. Laparoscopic Technique for Serial Collection of Liver and Mesenteric Lymph Nodes in Macaques , 2017, Journal of visualized experiments : JoVE.
[29] J. Schiffer,et al. Autologous Stem Cell Transplantation Disrupts Adaptive Immune Responses during Rebound Simian/Human Immunodeficiency Virus Viremia , 2017, Journal of Virology.
[30] Daniel I. S. Rosenbloom,et al. Proliferation of latently infected CD4+ T cells carrying replication-competent HIV-1: Potential role in latent reservoir dynamics , 2017, The Journal of experimental medicine.
[31] R. Sékaly,et al. Loss of immune homeostasis dictates SHIV rebound after stem-cell transplantation. , 2017, JCI insight.
[32] D. Fuller,et al. Laparoscopic Technique for Serial Collection of Para-Colonic, Left Colic, and Inferior Mesenteric Lymph Nodes in Macaques , 2016, PloS one.
[33] R. Siliciano,et al. HIV reservoirs: what, where and how to target them , 2015, Nature Reviews Microbiology.
[34] D. O’Connor,et al. Expansion of Simian Immunodeficiency Virus (SIV)-Specific CD8 T Cell Lines from SIV-Naive Mauritian Cynomolgus Macaques for Adoptive Transfer , 2015, Journal of Virology.
[35] N. Kröger,et al. Donor Lymphocyte Infusions for Chronic Myeloid Leukemia Relapsing after Allogeneic Stem Cell Transplantation: May We Predict Graft-versus-Leukemia Without Graft-versus-Host Disease? , 2015, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
[36] K. MacDonald,et al. A critical analysis of the cynomolgus macaque, Macaca fascicularis, as a model to test HIV-1/SIV vaccine efficacy. , 2015, Vaccine.
[37] A. Haase,et al. Large number of rebounding/founder HIV variants emerge from multifocal infection in lymphatic tissues after treatment interruption , 2015, Proceedings of the National Academy of Sciences.
[38] Emily B Hanhauser,et al. Antiretroviral-Free HIV-1 Remission and Viral Rebound After Allogeneic Stem Cell Transplantation , 2014, Annals of Internal Medicine.
[39] G. Silvestri,et al. Persistence of Virus Reservoirs in ART-Treated SHIV-Infected Rhesus Macaques after Autologous Hematopoietic Stem Cell Transplant , 2014, PLoS pathogens.
[40] Jinyan Liu,et al. Rapid Seeding of the Viral Reservoir Prior to SIV Viremia in Rhesus Monkeys , 2014, Nature.
[41] J. Mellors,et al. Impact of Chemotherapy for HIV-1 Related Lymphoma on Residual Viremia and Cellular HIV-1 DNA in Patients on Suppressive Antiretroviral Therapy , 2014, PloS one.
[42] Sarah B. Laskey,et al. Replication-Competent Noninduced Proviruses in the Latent Reservoir Increase Barrier to HIV-1 Cure , 2013, Cell.
[43] A. Krishnan,et al. Plasma Viremia and Cellular HIV-1 DNA Persist Despite Autologous Hematopoietic Stem Cell Transplantation for HIV-Related Lymphoma , 2013, Journal of acquired immune deficiency syndromes.
[44] A. LaCasce,et al. Long-term reduction in peripheral blood HIV type 1 reservoirs following reduced-intensity conditioning allogeneic stem cell transplantation. , 2013, The Journal of infectious diseases.
[45] Melisa L. Budde,et al. Adoptive Transfer of Lymphocytes Isolated from Simian Immunodeficiency Virus SIVmac239Δnef-Vaccinated Macaques Does Not Affect Acute-Phase Viral Loads but May Reduce Chronic-Phase Viral Loads in Major Histocompatibility Complex-Matched Recipients , 2013, Journal of Virology.
[46] J. Hoxie,et al. Blockade of lymphocyte chemotaxis in visceral graft-versus-host disease. , 2012, The New England journal of medicine.
[47] Melisa L. Budde,et al. Specific CD8+ T Cell Responses Correlate with Control of Simian Immunodeficiency Virus Replication in Mauritian Cynomolgus Macaques , 2012, Journal of Virology.
[48] E. Thiel,et al. Evidence for the cure of HIV infection by CCR5Δ32/Δ32 stem cell transplantation. , 2011, Blood.
[49] E. Elder,et al. GVHD after haploidentical transplantation: a novel, MHC-defined rhesus macaque model identifies CD28- CD8+ T cells as a reservoir of breakthrough T-cell proliferation during costimulation blockade and sirolimus-based immunosuppression. , 2010, Blood.
[50] Melisa L. Budde,et al. Characterization of Mauritian cynomolgus macaque major histocompatibility complex class I haplotypes by high-resolution pyrosequencing , 2010, Immunogenetics.
[51] R. Talamini,et al. Immune recovery after autologous stem cell transplantation is not different for HIV-infected versus HIV-uninfected patients with relapsed or refractory lymphoma. , 2010, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[52] Melisa L. Budde,et al. Extralymphoid CD8+ T Cells Resident in Tissue from Simian Immunodeficiency Virus SIVmac239Δnef-Vaccinated Macaques Suppress SIVmac239 Replication Ex Vivo , 2010, Journal of Virology.
[53] E. Thiel,et al. Long-term control of HIV by CCR5 Delta32/Delta32 stem-cell transplantation. , 2009, The New England journal of medicine.
[54] Geneviève Boucher,et al. HIV reservoir size and persistence are driven by T cell survival and homeostatic proliferation , 2009, Nature Medicine.
[55] L. Picker,et al. Profound CD4+/CCR5+ T cell expansion is induced by CD8+ lymphocyte depletion but does not account for accelerated SIV pathogenesis , 2009, Journal of Experimental Medicine.
[56] R. Siliciano,et al. A Simian Immunodeficiency Virus-Infected Macaque Model To Study Viral Reservoirs That Persist during Highly Active Antiretroviral Therapy , 2009, Journal of Virology.
[57] Jennifer J. Lhost,et al. Mauritian Cynomolgus Macaques Share Two Exceptionally Common Major Histocompatibility Complex Class I Alleles That Restrict Simian Immunodeficiency Virus-Specific CD8+ T Cells , 2009, Journal of Virology.
[58] D. Burton,et al. Macaques vaccinated with live-attenuated SIV control replication of heterologous virus , 2008, The Journal of experimental medicine.
[59] M. Muñoz-Fernández,et al. Short communication: Immune reconstitution after autologous peripheral blood stem cell transplantation in HIV-infected patients: might be better than expected? , 2007, AIDS research and human retroviruses.
[60] A. Hughes,et al. Comprehensive characterization of MHC class II haplotypes in Mauritian cynomolgus macaques , 2007, Immunogenetics.
[61] D. Watkins,et al. Subdominant CD8+ T-Cell Responses Are Involved in Durable Control of AIDS Virus Replication , 2007, Journal of Virology.
[62] D. O’Connor,et al. Simian Immunodeficiency Virus SIVmac239 Infection of Major Histocompatibility Complex-Identical Cynomolgus Macaques from Mauritius , 2006, Journal of Virology.
[63] J. Mascola,et al. Pathogenicity of Simian-Human Immunodeficiency Virus SHIV-89.6P and SIVmac Is Attenuated in Cynomolgus Macaques and Associated with Early T-Lymphocyte Responses , 2005, Journal of Virology.
[64] Matthew C Strain,et al. Effect of treatment, during primary infection, on establishment and clearance of cellular reservoirs of HIV-1. , 2005, The Journal of infectious diseases.
[65] R. Siliciano,et al. Resting CD4+ T Lymphocytes but Not Thymocytes Provide a Latent Viral Reservoir in a Simian Immunodeficiency Virus-Macaca nemestrina Model of Human Immunodeficiency Virus Type 1-Infected Patients on Highly Active Antiretroviral Therapy , 2003, Journal of Virology.
[66] R. Lempicki,et al. HIV-1 and T cell dynamics after interruption of highly active antiretroviral therapy (HAART) in patients with a history of sustained viral suppression. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[67] J. Schmitz,et al. A nonhuman primate model for the selective elimination of CD8+ lymphocytes using a mouse-human chimeric monoclonal antibody. , 1999, The American journal of pathology.
[68] J. Lisziewicz,et al. Latent infection of CD4+ T cells provides a mechanism for lifelong persistence of HIV-1, even in patients on effective combination therapy , 1999, Nature Medicine.
[69] M A Nowak,et al. Presence of an inducible HIV-1 latent reservoir during highly active antiretroviral therapy. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[70] R Brookmeyer,et al. Identification of a reservoir for HIV-1 in patients on highly active antiretroviral therapy. , 1997, Science.
[71] R. Siliciano,et al. Quantification of latent tissue reservoirs and total body viral load in HIV-1 infection , 1997, Nature.
[72] R. Sussman,et al. Mitochondrial DNA of the Mauritian macaques (Macaca fascicularis): an example of the founder effect. , 1995, American journal of physical anthropology.
[73] L. Picker,et al. In Vivo Validation of the Viral Barcoding of Simian Immunodeficiency Virus SIVmac239 and the Development of New Barcoded SIV and Subtype B and C Simian-Human Immunodeficiency Viruses , 2019, Journal of Virology.
[74] S. Pavletic,et al. Bronchiolitis obliterans syndrome after allogeneic hematopoietic stem cell transplantation-an increasingly recognized manifestation of chronic graft-versus-host disease. , 2010, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
[75] V. Calvez,et al. High-dose therapy plus autologous hematopoietic stem cell transplantation for human immunodeficiency virus (HIV)-related lymphoma: results and impact on HIV disease. , 2004, Haematologica.